Open AccessChemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
Author(s) -
Long Bai,
Feng Wang,
Z. M. Li,
Chao Ren,
Dongsheng Zhang,
Qian Zhao,
Yong Lu,
De-Shen Wang,
HuaiQiang Ju,
Miaozhen Qiu,
Zhiqiang Wang,
Fenghua Wang,
RuiHua Xu
Publication year - 2016
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000004531
Subject(s) - bevacizumab , medicine , cetuximab , kras , colorectal cancer , oncology , chemotherapy , population , proportional hazards model , cancer , environmental health
Supplemental Digital Content is available in the text